Considering HUMIRA for Juvenile Idiopathic Arthritis

If your child has been diagnosed with moderate to severe Juvenile Idiopathic Arthritis (JIA) and is still experiencing symptoms, HUMIRA may be able to help.

HUMIRA helps reduce pain, stiffness and swelling in children

HUMIRA is a treatment that may help to reduce the signs and symptoms of moderate to severe Juvenile Idiopathic Arthritis , even in children who have not been helped enough by other non-biologic medications. HUMIRA is usually used with methotrexate, or alone, when methotrexate is no longer working well enough, or no longer appropriate. HUMIRA may be an effective option for some children.

A clinical study showed you can expect fewer disease flares when treated with HUMIRA (both alone and in combination with methotrexate), compared to no HUMIRA treatment. It was also shown you may expect around 7 out of 10 children on HUMIRA alone, and 9 out of 10 children on HUMIRA and methotrexate, to experience a reduction in symptoms after four months of treatment.§

HUMIRA for Juvenile Idiopathic Arthritis in New Zealand

HUMIRA is only available on prescription for children with polyarticular JIA two years of age and older. Talk to your child’s rheumatologist or specialist to see if HUMIRA is right for them.

The government medicine funding agency, PHARMAC, fully subsidises HUMIRA for your child’s polyarticular JIA if they have not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your child’s specialist will discuss whether HUMIRA is right for your child, and whether your child may qualify for PHARMAC funded treatment. Usual doctor’s consultation fees, and pharmacy prescription charges remain payable by you.

Find out more from our list of useful resources about Juvenile Idiopathic Arthritis that has been collated from New Zealand and overseas.

HUMIRA Safety Information

Safety information on this website includes some of the more important information to know about HUMIRA.

Read More 

How does HUMIRA work?

HUMIRA is a fully human monoclonal antibody. HUMIRA recognises and binds to a specific protein (tumour necrosis factor or TNF-alpha), which is present at increased levels in inflammatory diseases such as Juvenile Idiopathic Arthritis.

Read More 

Starting and taking HUMIRA

What you need to know about taking HUMIRA, including free support to help you get the best out of your HUMIRA treatment.

Read More 


Will HUMIRA cure my/my child's disease?

Unfortunately, currently there are no treatments available that can cure polyarticular Juvenile Idiopathic Arthritis. HUMIRA will not cure your child’s condition but can help manage their symptoms.

When should I expect to see and feel an improvement?

HUMIRA can act quickly; most people with JIA can expect to see improvement in their symptoms within 4 months and in some cases as early as two weeks. Some patients may not respond within these timeframes. You’ll need to be patient and stay on track with your dosing schedule.